Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Medicentro Electrónica
versión On-line ISSN 1029-3043
Resumen
RIVERA TRUYT, Raúl; RIVERA CASTILLO, Therina y TIRADO SAURA, Sandra. COVID-19, its relationship with autoimmune diseases. Medicentro Electrónica [online]. 2022, vol.26, n.3, pp. 673-690. Epub 01-Sep-2022. ISSN 1029-3043.
Introduction:
COVID-19, in addition to spreading from person to person, threatens the economic and political stability of nations and has caused lethal respiratory infections in humans. This may be relevant when dealing with infection in an immunocompromised patient, potentially protected by a weaker immune response against infection.
Objective:
to describe the relationship of COVID-19 with some autoimmune diseases.
Methods:
the analysis-synthesis method, as well as the bibliographic and documentary analysis were used; the search engines were Hinari, Pubmed, ClinicalKey, SciELO regional, SciELO Cuba and Google Scholar.
Conclusions:
patients with autoimmune diseases are classified as risk patients. In case of being confirmed with COVID-19, most of their medications should be suspended and only maintain their treatments with hydroxychloroquine and IL-6 inhibitors in case of autoimmune arthritis, and glatiramer acetate in multiple sclerosis. These people must strictly follow the measures directed by the health authorities.
Palabras clave : arthritis, rheumatoid; multiple sclerosis; autoimmune diseases; Covid- 19.